Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use HEPZATO safely and effectively. See full prescribing information for HEPZATO KIT and HEPZATO KIT Hepatic Delivery System Instructions for Use. HEPZATO (melphalan) for injection is a component of the HEPZATO KIT Hepatic Delivery System (HDS) for intra-arterial use. Initial U.S. Approval: 1964
Medication labelWhy this: Advisory · dailymed-prescription
HEPZATO for injection, as a component of the HEPZATO KIT, is indicated as a liver-directed treatment for adult patients with uveal melanoma with unresectable hepatic metastases affecting less than 50% of the liver and no extrahepatic disease or extrahepatic disease limited to the bone, lymph nodes, subcutaneous tissues, or lung that is amenable to resection or radiation.
- generic_name
- melphalan hydrochloride injection, powder, lyophilized, for solution
- brand_name
- melphalan hydrochloride, sodium citrate, propylene glycol, alcohol, and water, sodium chloride and water
- product_names
- melphalan hydrochloride injection, powder, lyophilized, for solution, melphalan hydrochloride, sodium citrate, propylene glycol, alcohol, and water, sodium chloride and water
- ndc
- 75833-601, 75833-601-01, 75833-601-02, 75833-601-07, 75833-601-08, 75833-800, 75833-800-01, 75833-700, 75833-700-01, 75833-444, 75833-444-01
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en